# EDGAR Filing Document

**Accession Number:** 0001011060
**File Stem:** 0001493152-25-017947
**Filing Date:** 2025-10
**Character Count:** 10378
**Document Hash:** 8390409cce9f2dc15835874f97081f42
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-017947.hdr.sgml**: 20251014

**ACCESSION NUMBER**: 0001493152-25-017947

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251014

**DATE AS OF CHANGE**: 20251014

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nordicus Partners Corp
- **CENTRAL INDEX KEY:** 0001011060
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 043186647
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-48655
- **FILM NUMBER:** 251389964

**BUSINESS ADDRESS:**
- **STREET 1:** 280 SOUTH BEVERLY DR.
- **STREET 2:** SUITE 505
- **CITY:** BEVERLY HILLS
- **STATE:** CA
- **ZIP:** 90212
- **BUSINESS PHONE:** 508-523-3141

**MAIL ADDRESS:**
- **STREET 1:** 280 SOUTH BEVERLY DR.
- **STREET 2:** SUITE 505
- **CITY:** BEVERLY HILLS
- **STATE:** CA
- **ZIP:** 90212

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EKIMAS Corp
- **DATE OF NAME CHANGE:** 20200406

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AdvanSource Biomaterials Corp
- **DATE OF NAME CHANGE:** 20081021

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CARDIOTECH INTERNATIONAL INC
- **DATE OF NAME CHANGE:** 19960321
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GK Partners ApS
- **CENTRAL INDEX KEY:** 0001939150

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** G7
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**BUSINESS ADDRESS:**
- **STREET 1:** MESTERLODDEN 3B
- **CITY:** GENTOFTE
- **STATE:** G7
- **ZIP:** 2820
- **BUSINESS PHONE:** 45 42 90 17 33

**MAIL ADDRESS:**
- **STREET 1:** MESTERLODDEN 3B
- **CITY:** GENTOFTE
- **STATE:** G7
- **ZIP:** 2820

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Gk Partners ApS
- **DATE OF NAME CHANGE:** 20220721

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Nordicus Partners Corp**

*(Name of Issuer)*

**Common Stock**

*(Title of Class of Securities)*

**28265K205**

*(CUSIP Number)*

**GK Partners ApS**<br>Dyrehavevej 3B<br>Klampenborg G7 DK-2930<br>(45) 20 30 59 61

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**12/19/2024**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **28265K205** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**GK Partners ApS** | Name of reporting person<br>**GK Partners ApS** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**G7** | Citizenship or place of organization<br>**G7** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**3259025.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**3259025.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3259025.00** | Aggregate amount beneficially owned by each reporting person<br>**3259025.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**17.71%** | Percent of class represented by amount in Row (11)<br>**17.71%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock

**(b) Name of Issuer:**
Nordicus Partners Corp

**(c) Address of Issuer's Principal Executive Offices:**
280 South Beverly Drive, Suite 505, Beverly Hills, CA, 90212

**Item 4. Purpose of Transaction**

The following chart shows the Shares acquired and sold by GKP since the last Schedule 13D was filed by GKP on December 10, 2024:

Date                         Acquired/Disposed Shares Cost Basis           Note
December 19, 2024     Acquired              4,000     10.00       Warrant Exercised(1)
December 19, 2024     Acquired              6,000     10.00       Warrant Exercised
January 13, 2025         Acquired              1,504       8.97       Warrant Exercised
February 3, 2025         Acquired            11,528       4.00       Acquired in a private transaction
February 3, 2025         Disposed            -1,982       4.00       Sold in a private transaction
February 3, 2025         Disposed            -7,000       4.00       Sold in a private transaction
February 3, 2025         Disposed            -7,513       4.00       Sold in a private transaction
February 3, 2025         Disposed          -10,500       4.00       Sold in a private transaction
February 3, 2025         Disposed            -5,500       4.00       Sold in a private transaction
February 3, 2025         Disposed          -15,728       4.00       Sold in a private transaction
February 3, 2025         Disposed            -6,000       4.00       Sold in a private transaction
February 3, 2025         Disposed            -7,500       3.00       Sold in a private transaction
February 13, 2025       Acquired            11,224       8.91       Warrant Exercised
February 19, 2025       Disposed            -1,994       4.00       Sold in a private transaction
February 19, 2025       Disposed            -4,060       4.00       Sold in a private transaction
February 19, 2025       Disposed            -4,047       4.00       Sold in a private transaction
February 19, 2025       Disposed          -13,564       4.00       Sold in a private transaction
February 19, 2025       Disposed          -10,000       4.00       Sold in a private transaction
February 19, 2025       Disposed            -5,000       4.00       Sold in a private transaction
February 19, 2025       Disposed            -7,000       4.00       Sold in a private transaction
February 19, 2025       Disposed            -3,500       4.00       Sold in a private transaction
April 22, 2025              Acquired            10,000       5.00       Acquired via Subscription Agreement
May 2, 2025                 Acquired            21,000       5.00       Acquired via Subscription Agreement
May 16, 2025               Acquired            12,000       5.00       Acquired via Subscription Agreement
May 22, 2025               Acquired              6,000       5.00       Acquired via Subscription Agreement
May 28, 2025               Disposed        -109,750       0.00      Gifted in a private transaction
May 28, 2025               Acquired          113,095       0.00 Gifted from affiliate shareholder AC Nordic ApS
May 28, 2025               Disposed          -49,953       0.00      Gifted in a private transaction
June 16, 2025              Acquired              7,000       4.44       Acquired in a private transaction
August 8, 2025            Disposed          -23,300       2.00       Sold in a private transaction

(1) The shares that were issued pursuant to the exercise of the warrant refers to the warrant issued to GKP by the Company on April 1, 2022, to purchase 600,000 Shares at an exercise price of $10.00 per share (the "Warrant"). After giving effect to the transactions described in this Item, 0 shares remain unexercised under the Warrant.

The purpose of all of these transactions, both the acquisition and dispositions, was a part of the Reporting Person's long-term strategy for asset diversification and liquidity.

The foregoing transactions were exempt under the Securities Act of 1933, as amended (the "Securities Act"). None of such shares was or will be registered under the Securities Act or any state securities laws, and unless so registered, may not be reoffered or resold in the United States absent such registration or an applicable exemption therefrom, or in a transaction not subject to the registration requirements of the Securities Act of 1933 and other applicable securities laws.

**Item 5. Interest in Securities of the Issuer**

**(a)**
As of the date of this Schedule, the Reporting Person beneficially owned 3,259,025 Shares, constituting 17.71% of the outstanding Shares. The percentage of Shares owned is based upon 18,399,038 Shares outstanding as of September 30, 2025, based on inquiry of the Company's transfer agent.

**(b)**
GKP has the sole power to vote, direct the vote, dispose and direct the disposition of 3,259,025 Shares.

**(c)**
The Shares were acquired on the dates set forth above.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Except as described in Items 3 and 4, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Person and any other person with respect to any securities of the Company, including but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** GK Partners ApS

**Signature:** /s/ Tom Glaesner Larsen

**Name/Title:** Tom Glaesner Larsen

**Date:** 10/14/2025